集采政策对医疗机构心血管药品采购的影响研究

Study on the Impact of Centralized Volume-based Procurement Policy on the Procurement of Cardiovascular Drugs in Medical Institutions

目的:分析药品集采政策对不同等级医疗机构心血管药品采购的影响,为药品集采政策的调整与优化提供参考。方法:分析心血管药品在各级医疗机构的采购量变化情况,采用Mann-Kendall(M-K)趋势性检验判断心血管药品采购量的长期变化趋势。结果:药品集采政策实施后,心血管药品中选产品采购量大幅增长;各级医疗机构集采品种采购量增幅随采购周期的延长而降低;试点地区基层医疗机构中选产品采购量显著增长,联盟地区仅基层医疗机构非中选产品采购量显著下降,基层医疗机构可替代品种采购量呈下降趋势。结论:药品集采政策效应可能存在滞后性,且随采购周期的延长而逐渐弱化,可替代品种的采购量增长值得进一步关注。

Objective To analyze the impact of centralized volume-based procurement policy on cardiovascular drugs procurement in different levels of medical institutions,and to provide reference for the adjustment and optimization of centralized volume-based procurement policy.Methods Descriptive study was used to analyze the changes in the procurement volume of cardiovascular policy-related drugs in medical institutions at all levels.Mann-Kendall(M-K)trend test was used to estimate the long-term change trend of cardiovascular policy-related drugs.Results After the implementation of the policy,the procurement volume of selected products of cardiovascular drugs increased significantly and primary medical institutions had the largest increase.The increase of selected drugs in medical institutions at all levels decreased with the lengthening of procurement cycle.The procurement volume of selected products in the primary medical institutions in the pilot areas increased significantly.The procurement volume of non-selected products in the alliance areas only for the primary medical institutions decreased significantly,and the procurement volume of alternative drugs in primary medical institutions showed a decreasing trend.Conclusion The effect of centralized volume-based procurement policy may have a lag and gradually weaken with the lengthening of the procurement cycle,and the growth of the procurement volume of alternative drugs deserves further attention.